Alexandra V. Bruter

Anti-Cancer Potential of Transiently Transfected HER2-Specific Human Mixed CAR-T and NK Cell Populations in Experimental Models: Initial Studies on Fucosylated Chondroitin Sulfate Usage for Safer Treatment

N. Nifantiev, I. Chikileva, I. Shubina, 2023, Biomedicines.

CDK8/19 Inhibition Attenuates G1 Arrest Induced by BCR-ABL Antagonists and Accelerates Death of Chronic Myelogenous Leukemia Cells

Alexander V. Tyakht, I. Roninson, A. Khamidullina, 2023, bioRxiv.

Genetically modified mice as a tool for the study of human diseases.

V. Tatarskiy, Alexandra V. Bruter, Ekaterina A. Varlamova, 2024, Molecular biology reports.

Knockout of cyclin dependent kinases 8 and 19 leads to depletion of cyclin C and suppresses spermatogenesis and male fertility in mice

A. Khamidullina, Mengqian Chen, V. Tatarskiy, 2024, bioRxiv.

CD52/FLAG and CD52/HA Fusion Proteins as Novel Magnetic Cell Selection Markers

A. Belyavsky, O. Kandarakov, Alexandra V. Bruter, 2024, International Journal of Molecular Sciences.

Key Proteins of Replication Stress Response and Cell Cycle Control as Cancer Therapy Targets

A. Khamidullina, V. Tatarskiy, Alexandra V. Bruter, 2024, International journal of molecular sciences.